These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22101984)

  • 21. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
    Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
    Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Notch1 enhances B-cell receptor-induced apoptosis in mature activated B cells without affecting cell cycle progression and surface IgM expression.
    Romer S; Saunders U; Jäck HM; Jehn BM
    Cell Death Differ; 2003 Jul; 10(7):833-44. PubMed ID: 12815466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression.
    Xiang X; Yuan D; Liu Y; Li J; Wen Q; Kong P; Gao L; Zhang C; Gao L; Peng X; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):800-806. PubMed ID: 30020405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The transgenic window on lymphoid malignancy.
    Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
    Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acceleration of B-lymphoid tumorigenesis in E mu-myc transgenic mice by v-H-ras and v-raf but not v-abl.
    Langdon WY; Harris AW; Cory S
    Oncogene Res; 1989; 4(4):253-8. PubMed ID: 2549487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas.
    Largaespada DA; Kaehler DA; Mishak H; Weissinger E; Potter M; Mushinski JF; Risser R
    Oncogene; 1992 Apr; 7(4):811-9. PubMed ID: 1565479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stage-specific transformation of murine B lineage cells by ras and myc.
    Overell RW; Weisser KE; Hess B; Namen AE; Grabstein KH
    Oncogene; 1989 Dec; 4(12):1425-32. PubMed ID: 2687765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bcl-2 and c-Myc co-operate in the Epstein-Barr virus-immortalized human B-cell line GM607 but do not confer tumorigenicity.
    Tomlin JL; Guinn BA; Penn LZ; Berinstein NL
    Leuk Lymphoma; 2005 Apr; 46(4):581-92. PubMed ID: 16019487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Transcription Factor ASCIZ and Its Target DYNLL1 Are Essential for the Development and Expansion of MYC-Driven B Cell Lymphoma.
    Wong DM; Li L; Jurado S; King A; Bamford R; Wall M; Walia MK; Kelly GL; Walkley CR; Tarlinton DM; Strasser A; Heierhorst J
    Cell Rep; 2016 Feb; 14(6):1488-1499. PubMed ID: 26832406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
    Schreiner S; Birke M; García-Cuéllar MP; Zilles O; Greil J; Slany RK
    Cancer Res; 2001 Sep; 61(17):6480-6. PubMed ID: 11522644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
    Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
    J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo.
    Blyth K; Vaillant F; Hanlon L; Mackay N; Bell M; Jenkins A; Neil JC; Cameron ER
    Cancer Res; 2006 Feb; 66(4):2195-201. PubMed ID: 16489021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
    Amanullah A; Liebermann DA; Hoffman B
    Oncogene; 2002 Feb; 21(10):1600-10. PubMed ID: 11896589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophages and abnormal BCL-6 or c-MYC gene expression affect the resistance of peritoneal B cells to induction of hyporesponsiveness.
    Liou LB; Wu MW; Chao WJ
    Scand J Immunol; 2009 May; 69(5):447-56. PubMed ID: 19508376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-221 redirects precursor B cells to the BM and regulates their residence.
    Knoll M; Simmons S; Bouquet C; Grün JR; Melchers F
    Eur J Immunol; 2013 Sep; 43(9):2497-506. PubMed ID: 23716169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The proto-oncogene c-myc regulates antibody secretion and Ig class switch recombination.
    Fernández D; Ortiz M; Rodríguez L; García A; Martinez D; Moreno de Alborán I
    J Immunol; 2013 Jun; 190(12):6135-44. PubMed ID: 23690468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging.
    Blyth K; Terry A; Mackay N; Vaillant F; Bell M; Cameron ER; Neil JC; Stewart M
    Oncogene; 2001 Jan; 20(3):295-302. PubMed ID: 11313958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation.
    Gao X; Liu X; Lu Y; Wang Y; Cao W; Liu X; Hu H; Wang H
    Breast Cancer; 2019 Sep; 26(5):663-671. PubMed ID: 30989585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The chromatin remodeler Brg1 activates enhancer repertoires to establish B cell identity and modulate cell growth.
    Bossen C; Murre CS; Chang AN; Mansson R; Rodewald HR; Murre C
    Nat Immunol; 2015 Jul; 16(7):775-84. PubMed ID: 25985234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer.
    Mikkers H; Allen J; Knipscheer P; Romeijn L; Hart A; Vink E; Berns A
    Nat Genet; 2002 Sep; 32(1):153-9. PubMed ID: 12185366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.